Cargando…
Nanocarriers for ocular drug delivery: Recent advances and future opportunities
Topical route of administration is very important and the most commonly used method of drug delivery for treatment of ocular diseases. However, due to unique anatomical and physiological barriers of eye, it is difficult to achieve the therapeutic concentration in the targeted tissue within the eye....
Autores principales: | Amrutkar, Chetan S, Patil, Sanjay B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418032/ https://www.ncbi.nlm.nih.gov/pubmed/37322644 http://dx.doi.org/10.4103/ijo.IJO_1893_22 |
Ejemplares similares
-
Nanocarriers for ocular drug delivery: current status and translational opportunity
por: Gorantla, Srividya, et al.
Publicado: (2020) -
Recent advances of drug delivery nanocarriers in osteosarcoma treatment
por: Wang, Shang-Yu, et al.
Publicado: (2020) -
Nanotechnology-based ocular drug delivery systems: recent advances and future prospects
por: Li, Shiding, et al.
Publicado: (2023) -
Niosomal Drug Delivery Systems for Ocular Disease—Recent Advances and Future Prospects
por: Durak, Saliha, et al.
Publicado: (2020) -
Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system
por: Sun, Xiangyu, et al.
Publicado: (2023)